摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[2-(methylaminomethyl)morpholino]-4-oxoquinoline-3-carboxylic acid | 122910-81-0

中文名称
——
中文别名
——
英文名称
1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[2-(methylaminomethyl)morpholino]-4-oxoquinoline-3-carboxylic acid
英文别名
3-Quinolinecarboxylic acid, 1,4-dihydro-1-cyclopropyl-6,8-difluoro-7-(2-((methylamino)methyl)-4-morpholinyl)-4-oxo-;1-cyclopropyl-6,8-difluoro-7-[2-(methylaminomethyl)morpholin-4-yl]-4-oxoquinoline-3-carboxylic acid
1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[2-(methylaminomethyl)morpholino]-4-oxoquinoline-3-carboxylic acid化学式
CAS
122910-81-0
化学式
C19H21F2N3O4
mdl
——
分子量
393.39
InChiKey
NTBFOBUDTNNTGO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.1
  • 重原子数:
    28
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    82.1
  • 氢给体数:
    2
  • 氢受体数:
    9

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[2-(methylaminomethyl)morpholino]-4-oxoquinoline-3-carboxylic acid 生成 1-Cyclopropyl-6,8-difluoro-7-[2-(methylaminomethyl)morpholin-4-yl]-4-oxoquinoline-3-carboxylic acid;hydrochloride
    参考文献:
    名称:
    ARAKI, KAZUHIKO;KURODA, TSUYOSHI;UEMORI, SATORU;MORIGUCHI, AKIHIKO;IKEDA,+
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    Quinolone antimicrobial agents substituted with morpholines at the 7-position. Syntheses and structure-activity relationships
    摘要:
    A series of novel 7-substituted 1-cyclopropyl-6,8-difluoro- 1,4-dihydro-4-oxo-3-quinolinecarboxylic acids have been prepared and tested for antibacterial activities and for convulsive activities in combination with nonsteroidal antiinflammatory drug. Structure-activity relationships revealed that 7-(2-(aminomethyl)morpholino) derivative 28 had a better Gram-positive activity than the reference quinolones, such as ciprofloxacin, norfloxacin, and ofloxacin. Its Gram-negative activity was equipotent with those of norfloxacin and ofloxacin but was inferior to that of ciprofloxacin. In mouse systemic infection models, 28 showed an excellent therapeutic efficacy which might result from the potent antibacterial activity and suitable physicochemical properties. Convulsive activities of 7-morpholino derivatives in combination with nonsteroidal antiinflammatory drug fenbufen or its metabolite biphenylacetic acid markedly diminished as compared to those of 7-piperazino derivatives in the electrophysiological, biochemical, and behavioral experiments. These results suggest that 28 (Y-26611) is a novel quinolone with reduced neurotoxic excitatory adverse reaction.
    DOI:
    10.1021/jm00062a007
点击查看最新优质反应信息

文献信息

  • Quinolonecarboxylic acid compounds and pharmaceutical use thereof
    申请人:Yoshitomi Pharmaceutical Industries, Ltd.
    公开号:US04889857A1
    公开(公告)日:1989-12-26
    A quinolonecarboxylic acid compound of the formula: ##STR1## wherein R.sup.1 is an alkyl group, a cycloalkyl group, a haloalkyl group, an alkenyl group, mono- or di-alkylamino groups, a phenyl group or a phenyl group substituted by one to three substituents selected from the group consisting of a halogen atom, an alkyl group, an alkoxy group, a hydroxy group, a nitro group or an amino group, R.sup.2 is a hydrogen atom, an alkyl group, a cycloalkyl group, an acyl group or an alkoxycarbonyl group, R.sup.3 is a hydrogen atom, an alkyl group or an aralkyl group, or R.sup.2 and R.sup.3 together with the adjacent nitrogen atom form a heterocyclic ring, R.sup.4 is a hydrogen atom or an alkyl group, R.sup.5 is a hydrogen atom, an alkyl group, an aralkyl group or an ester residue which is readily hydrolyzable in vivo, X is a hydrogen atom, a halogen atom or an alkyl group, n is interger of 1 to 3, and a salt thereof, and pharmaceutical use thereof. The compounds exhibit antibacterial activites and are useful for the treatment of various infectious diseases.
    一种喹诺酮羧酸化合物,其结构式如上:##STR1##其中,R1为烷基、环烷基、卤代烷基、烯基、单或双烷基氨基、苯基或被一个至三个选自卤素、烷基、烷氧基、羟基、硝基或氨基的取代基取代的苯基;R2为氢、烷基、环烷基、酰基或烷氧羰基;R3为氢、烷基或芳烷基,或者R2和R3与相邻的氮原子一起形成杂环;R4为氢或烷基;R5为氢、烷基、芳烷基或体内易水解的酯残基;X为氢、卤素或烷基;n为1至3的整数;及其盐,以及其在医药上的用途。这些化合物具有抗菌活性,可用于治疗各种感染性疾病。
  • ARAKI, KAZUHIKO;KURODA, TSUYOSHI;UEMORI, SATORU;MORIGUCHI, AKIHIKO;IKEDA,+
    作者:ARAKI, KAZUHIKO、KURODA, TSUYOSHI、UEMORI, SATORU、MORIGUCHI, AKIHIKO、IKEDA,+
    DOI:——
    日期:——
  • ARAKI, KADZUXIKO;KURODA, TAKEHSI;UEHMORI, SATORU;MORIGUTI, AKIXIKO;IKEHDA+
    作者:ARAKI, KADZUXIKO、KURODA, TAKEHSI、UEHMORI, SATORU、MORIGUTI, AKIXIKO、IKEHDA+
    DOI:——
    日期:——
  • JPH02138278A
    申请人:——
    公开号:JPH02138278A
    公开(公告)日:1990-05-28
  • JPH03148276A
    申请人:——
    公开号:JPH03148276A
    公开(公告)日:1991-06-25
查看更多